Table 3.
The 68 discriminating m/z peaks among CRC and normal controls
| m/z | p | m/z | p | m/z | p | m/z | p | m/z | p |
|---|---|---|---|---|---|---|---|---|---|
| 5635.3 | 2.0×10-8 | 11513.2 | 3.2×10-6 | 4599.1 | 1.2×10-5 | 9498.9 | 6.8×10-5 | 4112.6 | 8.6×10-4 |
| 4284.5 | 4.2×10-8 | 13748.8* | 3.5×10-6 | 6837.5 | 1.5×10-5 | 23415.8 | 7.9×10-5 | 4159.9 | 8.9×10-4 |
| 2870. 7* | 4.9×10-8 | 2915.8 | 4.6×10-6 | 2949.1 | 1.9×10-5 | 2744.9 | 2.5×10-4 | 7628.5 | 9.1×10-4 |
| 4476.5 | 7.3×10-8 | 5910.8 | 5.1×10-6 | 3400.7 | 2.1×10-5 | 2800.6 | 3.6×10-4 | 6435.3 | 9.5×10-4 |
| 9180.5* | 1.5×10-7 | 5703.4 | 5.8×10-6 | 3817.5 | 2.3×10-5 | 3377.9 | 4.5×10-4 | 7564.4 | 0.001 |
| 2894.6 | 2.2×10-7 | 3320.4 | 6.3×10-6 | 5905.1 | 2.4×10-5 | 6361. 8 | 5.1×10-4 | 3692.4 | 0.001 |
| 3084* | 4.5×10-7 | 3975.31 | 6.8×10-6 | 3219.4 | 2.9×10-5 | 14784.8 | 5.5×10-4 | 7839.8 | 0.001 |
| 4452.9 | 5.8×10-7 | 4647.4 | 7.1×10-6 | 6194.6 | 3.3×10-5 | 18378.9 | 5.7×10-4 | 9342.9 | 0.002 |
| 5213 | 6.4×10-7 | 9286.1 | 7.4×10-6 | 4703.3 | 3.8×10-5 | 4387.29 | 5.8×10-4 | 24092.6 | 0.004 |
| 4945.9 | 8.8×10-7 | 2152.5 | 8.9×10-6 | 2686.1 | 4.1×10-5 | 4350.5 | 6.5×10-4 | 4299.3 | 0.004 |
| 9713.5 | 9.8×10-7 | 15114.2 | 9.2×10-6 | 5545.4 | 4.5×10-5 | 5479.3 | 6.6×10-4 | 7941 | 0.006 |
| 8564.3 | 9.9×10-7 | 2545.7 | 9.4×10-6 | 13270.1 | 4.6×10-5 | 11076.0 | 7.0×10-4 | 15309 | 0.009 |
| 5809.6 | 1.1×10-6 | 8146.1 | 9.6×10-6 | 4985.2 | 6.2×10-5 | 6883.3 | 7.5×10-4 | 2821.5 | 0.009 |
| 3089.7 | 2.0×10-7 | 2756.8 | 9.9×10-6 | 5504.8 | 6.3×10-5 | N/A | N/A | N/A | N/A |
m/z means mass-to-charge ratio. P was generated by peak comparison between CRC and normal controls. Peaks labeled by * were selected as biomarkers for CRC diagnostic model.